Mild antithrombin deficiency and risk of recurrent venous thromboembolism: A prospective cohort study

Circulation

Volumn 129, Issue 4, 2014, Pages 497-503

  Di Minno, Matteo Nicola Dario ^a   Dentali, Francesco ^b   Lupoli, Roberta ^a   Ageno, Walter ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Antithrombin; Thromboembolism; Thrombophilia

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; ANTIVITAMIN K; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ANTICOAGULANT THERAPY; ANTITHROMBIN DEFICIENCY; ARTICLE; BLEEDING; COHORT ANALYSIS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONJUNCTIVAL HEMORRHAGE; DEEP VEIN THROMBOSIS; ECHOGRAPHY; EPISTAXIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMARTHROSIS; HEMATURIA; HEMOPTYSIS; HUMAN; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MENORRHAGIA; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL BLEEDING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM HEMORRHAGE; RECURRENCE RISK; RECURRENT DISEASE; RISK ASSESSMENT; SECONDARY PREVENTION; TREATMENT DURATION; VENOUS THROMBOEMBOLISM;

ANTITHROMBIN; THROMBOEMBOLISM; THROMBOPHILIA;

ADULT; ANTITHROMBIN III DEFICIENCY; ANTITHROMBINS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VENOUS THROMBOEMBOLISM;

EID: 84893424375     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.113.003756     Document Type: Article

References (33)

1. Anderson FA Jr, Brownell Wheeler H, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, Forcier A, Dalen JE. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: The Worcester DVT Study. Arch Intern Med. 1991;151:933-938
2. Prandoni P, Lensing AW, Cogo A, Cuppini S, Villalta S, Carta M, Cattelan AM, Polistena P, Bernardi E, Prins MH. The long-Term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125:1-7
3. Rosendaal FR. Venous thrombosis: A multicausal disease. Lancet. 1999;353:1167-1173
4. Seligsohn U, Zivelin A. Thrombophilia as a multigenic disorder. Thromb Haemost. 1997;78:297-301
5. Bovill EG, Hasstedt SJ, Leppert MF, Long GL. Hereditary thrombophilia as a model for multigenic disease. Thromb Haemost. 1999;82:662-666
6. De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: Pathogenesis, clinical syndromes, and management. Blood. 1996;87:3531-3544
7. Lane DA, Bayston T, Olds RJ, Fitches AC, Cooper DN, Millar DS, Jochmans K, Perry DJ, Okajima K, Thein SL, Emmerich J; for the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Antithrombin mutation database: 2nd (1997) update. Thromb Haemost. 1997;77:197-211
8. Simioni P, Sanson BJ, Prandoni P, Tormene D, Friederich PW, Girolami B, Gavasso S, Huisman MV, Büller HR, Wouter ten Cate J, Girolami A, Prins MH. Incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost. 1999;81:198-202
9. Sanson BJ, Simioni P, Tormene D, Moia M, Friederich PW, Huisman MV, Prandoni P, Bura A, Rejto L, Wells P, Mannucci PM, Girolami A, Büller HR, Prins MH. The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: A prospective cohort study. Blood. 1999;94:3702-3706
10. De Stefano V, Leone G, Mastrangelo S, Tripodi A, Rodeghiero F, Castaman G, Barbui T, Finazzi G, Bizzi B, Mannucci PM. Clinical manifestations and management of inherited thrombophilia: Retrospective analysis and followup after diagnosis of 238 patients with congenital deficiency of antithrombin III, protein C, protein S. Thromb Haemost. 1994;72:352-358
11. Martinelli I, Mannucci PM, De Stefano V, Taioli E, Rossi V, Crosti F, Paciaroni K, Leone G, Faioni EM. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: A study of 150 families. Blood. 1998;92:2353-2358
12. De Stefano V. Inherited thrombophilia and life-Time risk of venous thromboembolism: Is the burden reducible? J Thromb Haemost. 2004;2:1522-1525
13. Vossen CY, Conard J, Fontcuberta J, Makris M, Van Der Meer FJ, Pabinger I, Palareti G, Preston FE, Scharrer I, Souto JC, Svensson P, Walker ID, Rosendaal FR. Familial thrombophilia and lifetime risk of venous thrombosis. J Thromb Haemost. 2004;2:1526-1532
14. Vossen CY, Conard J, Fontcuberta J, Makris M, VAN DER Meer FJ, Pabinger I, Palareti G, Preston FE, Scharrer I, Souto JC, Svensson P, Walker ID, Rosendaal FR. Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect: The European Prospective Cohort on Thrombophilia (EPCOT). J Thromb Haemost. 2005;3:459-464
15. Dentali F, Gianni M. VTE recurrence in patients with inherited deficiencies of natural anticoagulants. Thromb Haemost. 2009;101:5-6
16. Ho WK, Hankey GJ, Quinlan DJ, Eikelboom JW. Risk of recurrent venous thromboembolism in patients with common thrombophilia: A systematic review. Arch Intern Med. 2006;166:729-736
17. Tait RC, Walker ID, Perry DJ, Islam SI, Daly ME, McCall F, Conkie JA, Carrell RW. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol. 1994;87:106-112
18. Patnaik MM, Moll S. Inherited antithrombin deficiency: A review. Haemophilia. 2008;14:1229-1239
19. Di Minno MN, Dentali F, Veglia F, Russolillo A, Tremoli E, Ageno W. Antithrombin levels and the risk of a first episode of venous thromboembolism: A case-control study. Thromb Haemost. 2013;109:167-169
20. Bucciarelli P, Passamonti SM, Biguzzi E, Gianniello F, Franchi F, Mannucci PM, Martinelli I. Low borderline plasma levels of antithrombin, protein C and protein S are risk factors for venous thromboembolism. J Thromb Haemost. 2012;10:1783-1791
21. Di Minno MN, Tufano A, Guida A, Di Capua M, De Gregorio AM, Cerbone AM, Tarantino G, Di Minno G. Abnormally high prevalence of major components of the metabolic syndrome in subjects with early-onset idiopathic venous thromboembolism. Thromb Res. 2011;127:193-197
22. Di Minno MN, Pezzullo S, Palmieri V, Di Somma C, Lupoli R, Valle D, Lombardi G, Di Minno G. Protein C and protein S changes in GH-deficient adults on r-HGH replacement therapy: Correlations with PAI-1 and t-PA plasma levels. Thromb Res. 2010;126:e434-e438
23. Mangia A, Margaglione M, Cascavilla I, Gentile R, Cappucci G, Facciorusso D, Grandone E, Di Minno G, Rizzetto M, Andriulli A. Anticardiolipin antibodies in patients with liver disease. Am J Gastroenterol. 1999;94:2983-2987
24. Madonna P, de Stefano V, Coppola A, Cirillo F, Cerbone AM, Orefice G, Di Minno G. Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke. Stroke. 2002;33:51-56
25. Prandoni P, Cogo A, Bernardi E, Villalta S, Polistena P, Simioni P, Noventa F, Benedetti L, Girolami A. A simple ultrasound approach for detection of recurrent proximal-vein thrombosis. Circulation. 1993;88(pt 1):1730-1735
26. Prandoni P, Lensing AW, Bernardi E, Villalta S, Bagatella P, Girolami A;DERECUS Investigators Group. The diagnostic value of compression ultrasonography in patients with suspected recurrent deep vein thrombosis. Thromb Haemost. 2002;88:402-406
27. Schulman S, Kearon C; Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3:692-694
28. Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M; STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration. Ann Intern Med. 2007;147:W163-W194
29. De Stefano V, Simioni P, Rossi E, Tormene D, Za T, Pagnan A, Leone G. The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S. Haematologica. 2006;91:695-698
30. Antón AI, Teruel R, Corral J, Miñano A, Martínez- Martínez I, Ordóñez A, Vicente V, Sánchez-Vega B. Functional consequences of the prothrombotic SERPINC1 rs2227589 polymorphism on antithrombin levels. Haematologica. 2009;94:589-592
31. Kearon C, Iorio A, Palareti G; Subcommittee on Control of Anticoagulation of the SSC of the ISTH. Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: Recommendation for acceptable rates and standardized reporting. J Thromb Haemost. 2010;8:2313-2315
32. Kearon C, Iorio A, Palareti G; Subcommittee on Control of Anticoagulation of the SSC of the ISTH. Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: Recommendation for acceptable rates and standardized reporting. J Thromb Haemost. 2010;8:2313-2315
33. Kearon C, Julian JA, Kovacs MJ, Anderson DR, Wells P, Mackinnon B, Weitz JI, Crowther MA, Dolan S, Turpie AG, Geerts W, Solymoss S, van Nguyen P, Demers C, Kahn SR, Kassis J, Rodger M, Hambleton J, Gent M, Ginsberg JS; ELATE Investigators. Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: Results from a randomized trial. Blood. 2008;112:4432-4436